Skip to article
Astra

Dermatology

Acanthosis Nigricans

Acanthosis nigricans should prompt etiologic triage rather than cosmetic treatment alone: most cases reflect obesity-associated insulin resistance, but abrupt generalized, mucosal, or nonobese presentations require evaluation for medication, endocrine, autoimmune, and malignant drivers.

Clinical question: How should clinicians evaluate acanthosis nigricans for metabolic disease, rare insulin-resistance syndromes, and internal malignancy?

First decision

Classify the presentation before ordering tests

The distribution, tempo, body habitus, and extracutaneous findings determine the initial workup.

Confirm the clinical phenotype: symmetric, hyperpigmented, velvety plaques with poorly defined borders, usually in intertriginous areas, support acanthosis nigricans. Skin tags commonly coexist around affected sites in insulin-resistant phenotypes. PubMedAcanthosis Nigricans: An Updated Review - PubMedPubMedA STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONS

The common branch is obesity-associated insulin resistance. In children, adolescents, and adults with overweight or central adiposity, neck and axillary involvement should redirect the encounter toward dysglycemia, dyslipidemia, hypertension, and fatty-liver risk rather than biopsy or lesion-directed therapy. Acanthosis nigricans identifies higher metabolic risk, but obesity is more predictive of insulin resistance than the skin finding alone. BMJType 2 diabetes in children - Symptoms, diagnosis and treatment | BMJ Best Practice USPubMedAn approach to acanthosis nigricans - PMCPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC

Escalate beyond routine metabolic assessment when lesions are abrupt, rapidly progressive, extensive or generalized, involve oral or other mucosa, or arise in a nonobese patient without an evident insulin-resistant state. Malignant lesions can be clinically indistinguishable from benign lesions; gastrointestinal adenocarcinoma, particularly gastric carcinoma, is the classic association. ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMedPubMedA STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONS

Clinical patterns that change the next diagnostic step. WileyISPAD Clinical Practice Consensus Guidelines 2022: Type 2 ...Wolters KluwerAutoimmune Forms of Hypoglycemia : MedicineScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMedPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC
PatternMost likely etiologic branchNext action
Gradual neck/axillary plaques with obesity or central adiposityObesity-associated insulin resistanceMeasure BMI and blood pressure; obtain fasting glucose, hemoglobin A1c, fasting lipid profile, and ALT. WHO[PDF] PHC ENG GUIDE 200 - Extranet SystemsPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC
Acanthosis nigricans with irregular menses, hirsutism, acne, or virilizationPCOS or another hyperandrogenic insulin-resistant stateEvaluate the hyperandrogenic syndrome and metabolic comorbidity burden. WileyISPAD Clinical Practice Consensus Guidelines 2022: Type 2 ...ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC
Severe generalized disease with marked hyperinsulinemia, dysglycemia, hypoglycemia, or autoimmune featuresType B insulin resistanceObtain paired glucose and insulin/C-peptide during the glycemic phenotype and pursue insulin-receptor antibody testing through an experienced center. WileyA case of type B insulin resistance presenting at a district general ...Wolters KluwerAutoimmune Forms of Hypoglycemia : Medicine
Abrupt, extensive, mucosal, or nonobese presentationMalignancy-associated acanthosis nigricansPerform symptom- and examination-directed evaluation for internal malignancy, with particular attention to gastrointestinal cancer. ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMedPubMedA STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONS

Common pathway

Evaluate obesity-associated acanthosis nigricans as a metabolic risk marker

The purpose of testing is to identify actionable dysglycemia and cardiometabolic comorbidity.

At the initial visit, record height, weight, BMI, waist or hip circumference when useful for adiposity assessment, and blood pressure. Examine for skin tags, hirsutism, goiter, abdominal tenderness or hepatomegaly, and broad pink striae when the history suggests endocrine disease. WHO[PDF] PHC ENG GUIDE 200 - Extranet SystemsPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC

Obtain fasting plasma glucose and hemoglobin A1c to detect dysglycemia, and obtain a fasting lipid profile to identify atherogenic dyslipidemia. Add ALT when obesity-associated metabolic dysfunction or hepatic steatosis is a concern; overweight and obese children with acanthosis nigricans have demonstrated higher fasting glycemia, insulin, HOMA index, triglyceride-related metabolic abnormalities, and aminotransferase levels than peers without lesions. WHO[PDF] PHC ENG GUIDE 200 - Extranet SystemsPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMC

Do not use acanthosis nigricans as a stand-alone proxy for insulin resistance or type 2 diabetes. In obese children, the presence of lesions is associated with insulin resistance, but obesity itself remains the more important determinant; a normal glucose result does not negate the need to address excess adiposity and longitudinal metabolic risk. PubMedAcanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children - PubMedPubMedAn approach to acanthosis nigricans - PMC

Escalation

Recognize endocrine, autoimmune, and malignancy-associated patterns

Rare causes matter when phenotype severity or clinical context is discordant with ordinary obesity-associated disease.

Consider endocrine-associated acanthosis nigricans when there are syndrome-specific findings. Hyperandrogenic and hypogonadal states, Cushing disease, Addison disease, hypothyroidism, and diabetes-related insulin resistance have been reported associations. In a patient with corresponding symptoms or examination findings, test for the suspected disorder rather than applying a broad endocrine panel. ScienceDirectAcanthosis nigricans, hypothyroidism, and insulin resistance - ScienceDirectScienceDirectAcanthosis Nigricans - an overview | ScienceDirect Topics

Type B insulin resistance is an autoimmune syndrome caused by insulin-receptor autoantibodies and can produce severe insulin resistance with hyperglycemia or, less often, hypoglycemia. During a spontaneous hypoglycemic event, obtain glucose with insulin, proinsulin, and C-peptide; confirmation requires insulin-receptor autoantibody detection. The coexistence of acanthosis nigricans, extreme hyperinsulinemic biochemistry, autoimmune features, and hyperandrogenism or female virilization should prompt urgent endocrinology involvement. WileyA case of type B insulin resistance presenting at a district general ...Wolters KluwerAutoimmune Forms of Hypoglycemia : Medicine

For suspected malignant acanthosis nigricans, use history and examination to direct cancer testing rather than assuming that lesion morphology distinguishes malignant from metabolic disease. Gastric carcinoma is the most common reported tumor association, and adenocarcinomas of the gastrointestinal tract, ovary, lung, and breast have been described. Mucosal involvement may include the oral cavity, nasal or laryngeal mucosa, or esophagus. ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedA STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONS

Treatment

Treat the underlying driver before cosmetic therapy

Improvement in plaques follows reduction of the pathogenic stimulus more reliably than lesion-only treatment.

For obesity-associated acanthosis nigricans, make weight reduction and treatment of insulin resistance the primary intervention. Weight loss can improve obesity-related disease, and control of hyperinsulinemia through dietary change may reduce lesion severity. Treat documented diabetes, dyslipidemia, hypertension, polycystic ovary syndrome, or suspected fatty-liver disease according to the relevant disease pathway. ScienceDirectSuccessful treatment of acanthosis nigricans with etretinate - ScienceDirectScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMed

When an identifiable medication is implicated, discontinue or substitute it when clinically feasible. If a defined endocrinopathy or internal malignancy is driving the lesions, direct treatment to that disorder; this approach may improve acanthosis nigricans and avoids ineffective escalation of cosmetic therapies. PubMedAcanthosis Nigricans: An Updated Review - PubMed

Use lesion-directed therapy only after addressing the driver and clarifying that evidence is largely symptomatic or cosmetic. Localized lesions may be treated with topical retinoids, vitamin D analogs, chemical peels, or other keratolytics; systemic oral retinoids have been considered for extensive, generalized, or topical-treatment–unresponsive disease. Laser therapy, dermabrasion, and surgical removal are less common options. PubMedAcanthosis Nigricans: An Updated Review - PubMed

Management priorities by etiologic branch. ScienceDirectSuccessful treatment of acanthosis nigricans with etretinate - ScienceDirectWolters KluwerAn approach to acanthosis nigricans : Indian Dermatology Online JournalScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMedPubMedAn approach to acanthosis nigricans - PMC
EtiologyPrimary interventionRole of skin-directed therapy
Obesity-associated insulin resistanceWeight reduction and treatment of documented metabolic comorbidities. ScienceDirectSuccessful treatment of acanthosis nigricans with etretinate - ScienceDirectScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMedConsider topical retinoids, vitamin D analogs, peels, or keratolytics for residual cosmetic concern. PubMedAcanthosis Nigricans: An Updated Review - PubMed
Medication-associated diseaseDiscontinue or replace the causative medication when feasible. PubMedAcanthosis Nigricans: An Updated Review - PubMedUse only if lesions remain bothersome after medication review. PubMedAcanthosis Nigricans: An Updated Review - PubMed
Endocrinopathy or PCOS-associated diseaseTreat the identified endocrine or hyperandrogenic disorder and associated insulin resistance. ScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMedPubMedAcanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMCAdjunctive only. PubMedAcanthosis Nigricans: An Updated Review - PubMed
Malignancy-associated diseaseTreat the underlying malignancy after directed diagnostic evaluation. PubMedAcanthosis Nigricans: An Updated Review - PubMedDo not allow cosmetic treatment to delay cancer evaluation. PubMedAcanthosis Nigricans: An Updated Review - PubMed
Type B insulin resistanceConfirm insulin-receptor autoantibodies and manage with specialized endocrinology input. Wolters KluwerAutoimmune Forms of Hypoglycemia : MedicineNo primary role until the systemic disorder is addressed. PubMedAcanthosis Nigricans: An Updated Review - PubMed

Diagnostic limits

Use biopsy selectively and refer for discordant disease

Histology may support the diagnosis but does not replace etiologic assessment.

Clinical diagnosis is usually sufficient when the morphology and metabolic context are typical. Consider dermatology evaluation and biopsy when morphology is atypical, distribution is unusual, facial pigmentation raises competing diagnoses, or a mimicker such as an acanthosis nigricans-like variant of mycosis fungoides is plausible. Patch-stage mycosis fungoides may require multiple skin biopsies. Oxford AcademicMycosis fungoides: a review - Oxford AcademicWolters KluwerFacial acanthosis nigricans − a narrative review : Pigment International

Refer urgently to endocrinology for suspected type B insulin resistance or severe dysglycemia with disproportionate hyperinsulinemia, and coordinate expedited malignancy evaluation for rapid, generalized, mucosal, or nonobese disease. The referral question should specify the phenotype, lesion tempo, glucose pattern, insulin/C-peptide results when obtained, medication exposures, and systemic cancer symptoms. WileyA case of type B insulin resistance presenting at a district general ...Wolters KluwerAutoimmune Forms of Hypoglycemia : MedicineScienceDirectAcanthosis Nigricans - an overview | ScienceDirect TopicsPubMedAcanthosis Nigricans: An Updated Review - PubMed

References

  1. [PDF] 210874Orig1s000 CLINICAL REVIEW(S) - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  2. Type 2 diabetes in children - Symptoms, diagnosis and treatment | BMJ Best Practice USbestpractice.bmj.com · bestpractice.bmj.com
  3. Cutaneous Manifestations of Internal Malignancyacsjournals.onlinelibrary.wiley.com · acsjournals.onlinelibrary.wiley.com
  4. Acanthosis nigricans: A review - Journal of Cosmetic Dermatologyonlinelibrary.wiley.com · onlinelibrary.wiley.com
  5. Cutaneous Manifestations of Internal Malignancy - Thiers - 2009 - CAacsjournals.onlinelibrary.wiley.com · acsjournals.onlinelibrary.wiley.com
  6. ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  7. Posters - 2017 - Australasian Journal of Dermatologyonlinelibrary.wiley.com · onlinelibrary.wiley.com
  8. Global hotspots and trends in Acanthosis nigricans research: A ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  9. A case of type B insulin resistance presenting at a district general ...wchh.onlinelibrary.wiley.com · wchh.onlinelibrary.wiley.com
  10. Acanthosis nigricans, hypothyroidism, and insulin resistance - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  11. Autoimmune Forms of Hypoglycemia : Medicinejournals.lww.com · journals.lww.com
  12. Acanthosis Nigricans Identifies Youth at High Risk for Metabolic Abnormalities - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  13. Mycosis fungoides: a review - Oxford Academicacademic.oup.com · academic.oup.com
  14. Successful treatment of acanthosis nigricans with etretinate - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  15. An approach to acanthosis nigricans : Indian Dermatology Online Journaljournals.lww.com · journals.lww.com
  16. Acanthosis Nigricans - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  17. Facial acanthosis nigricans − a narrative review : Pigment Internationaljournals.lww.com · journals.lww.com
  18. Acanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children - PubMedwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  19. [PDF] PHC ENG GUIDE 200 - Extranet Systemsextranet.who.int · extranet.who.int
  20. Predictors of Insulin Treatment During Pregnancy and Abnormal Postpartum Glucose Metabolism in Patients with Gestational Diabetes Mellitus - PubMedwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  21. Acanthosis Nigricans: An Updated Review - PubMedwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  22. An approach to acanthosis nigricans - PMCwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  23. A STUDY OF PATHOGENESIS OF ACANTHOSIS NIGRICANS AND ITS CLINICAL IMPLICATIONSpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  24. Acanthosis Nigricans – A Two-Sided Coin: Consider Metabolic Syndrome and Malignancies! - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov